Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10491139
[patent_doc_number] => 20150376161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'ANTIIFLAMMATORY AND ANTITUMOR 2-OXOTHIAZOLES ABD 2-OXOTHIOPHENES COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/764509
[patent_app_country] => US
[patent_app_date] => 2014-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24861
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14764509
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/764509 | ANTIIFLAMMATORY AND ANTITUMOR 2-OXOTHIAZOLES ABD 2-OXOTHIOPHENES COMPOUNDS | Jan 27, 2014 | Abandoned |
Array
(
[id] => 10476078
[patent_doc_number] => 20150361096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/762692
[patent_app_country] => US
[patent_app_date] => 2014-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27797
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762692
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/762692 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Jan 20, 2014 | Issued |
Array
(
[id] => 10476080
[patent_doc_number] => 20150361097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/762717
[patent_app_country] => US
[patent_app_date] => 2014-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22942
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14762717
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/762717 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Jan 20, 2014 | Issued |
Array
(
[id] => 9617028
[patent_doc_number] => 20140206886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'Enantioselective N-heterocyclic carbene-catalyzed annulation reactions with imidazolidinones'
[patent_app_type] => utility
[patent_app_number] => 13/999125
[patent_app_country] => US
[patent_app_date] => 2014-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17908
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13999125
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/999125 | Enantioselective N-heterocyclic carbene-catalyzed annulation reactions with imidazolidinones | Jan 15, 2014 | Issued |
Array
(
[id] => 9463380
[patent_doc_number] => 20140127807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'Method for Promoting Differentiation of Pluripotent Stem Cells into Cardiac Muscle Cells'
[patent_app_type] => utility
[patent_app_number] => 14/154765
[patent_app_country] => US
[patent_app_date] => 2014-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 14493
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14154765
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/154765 | Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells | Jan 13, 2014 | Issued |
Array
(
[id] => 11319294
[patent_doc_number] => 09518033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-13
[patent_title] => '(4E)-4-(4-substituted benzylideneamino)-2,3-dihydro-3-substituted-2-thioxothiazole-5-carbonitriles as A2AR antagonist and process for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 14/758994
[patent_app_country] => US
[patent_app_date] => 2014-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6717
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14758994
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/758994 | (4E)-4-(4-substituted benzylideneamino)-2,3-dihydro-3-substituted-2-thioxothiazole-5-carbonitriles as A2AR antagonist and process for preparation thereof | Jan 2, 2014 | Issued |
Array
(
[id] => 11198272
[patent_doc_number] => 09428474
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-30
[patent_title] => 'Antibacterial compounds'
[patent_app_type] => utility
[patent_app_number] => 14/654186
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13198
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654186
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654186 | Antibacterial compounds | Dec 19, 2013 | Issued |
Array
(
[id] => 10451955
[patent_doc_number] => 20150336967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Novel Benzimidazole Derivatives as Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/654779
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 40774
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654779
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654779 | Benzimidazole derivatives as Kinase Inhibitors | Dec 19, 2013 | Issued |
Array
(
[id] => 12305799
[patent_doc_number] => 09938299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Glycosidase inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/655222
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24657
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655222
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/655222 | Glycosidase inhibitors and uses thereof | Dec 19, 2013 | Issued |
Array
(
[id] => 10168208
[patent_doc_number] => 09198899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Dual-acting benzoimidazole antihypertensive agents'
[patent_app_type] => utility
[patent_app_number] => 14/132391
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60349
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132391
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/132391 | Dual-acting benzoimidazole antihypertensive agents | Dec 17, 2013 | Issued |
Array
(
[id] => 9477752
[patent_doc_number] => 20140135215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/108818
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21000
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14108818
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/108818 | CHEMICAL COMPOUNDS | Dec 16, 2013 | Abandoned |
Array
(
[id] => 9397030
[patent_doc_number] => 20140094436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/103420
[patent_app_country] => US
[patent_app_date] => 2013-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43056
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14103420
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/103420 | Imidazole compounds that modulate HSP90 activity | Dec 10, 2013 | Issued |
Array
(
[id] => 10103765
[patent_doc_number] => 09139540
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-09-22
[patent_title] => 'Method for preparation of 2-alkyl-1,2-benzisothiazolin-3-ones'
[patent_app_type] => utility
[patent_app_number] => 14/441875
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1871
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441875
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/441875 | Method for preparation of 2-alkyl-1,2-benzisothiazolin-3-ones | Nov 18, 2013 | Issued |
Array
(
[id] => 9546743
[patent_doc_number] => 20140171392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'Use of an Adrenal Hormone-Modifying Agent'
[patent_app_type] => utility
[patent_app_number] => 14/079018
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11134
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14079018
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/079018 | Use of an adrenal hormone-modifying agent | Nov 12, 2013 | Issued |
Array
(
[id] => 11225273
[patent_doc_number] => 09452988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Bendamustine derivatives and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 14/442088
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19749
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442088
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442088 | Bendamustine derivatives and methods of using same | Nov 11, 2013 | Issued |
Array
(
[id] => 10414168
[patent_doc_number] => 20150299178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'Thiazole Derivatives as Alpha 7 NACHR Modulators'
[patent_app_type] => utility
[patent_app_number] => 14/439120
[patent_app_country] => US
[patent_app_date] => 2013-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24860
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439120
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/439120 | Thiazole Derivatives as Alpha 7 NACHR Modulators | Nov 10, 2013 | Abandoned |
Array
(
[id] => 9339637
[patent_doc_number] => 20140066419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'HYDROXAMIC ACID DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/075145
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15548
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075145
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075145 | Hydroxamic acid derivatives | Nov 7, 2013 | Issued |
Array
(
[id] => 10389709
[patent_doc_number] => 20150274717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'Compositions And Methods For Treating Or Preventing Diseases Or Disorders Associated With Misregulated EIF4E'
[patent_app_type] => utility
[patent_app_number] => 14/437251
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 11011
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437251
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437251 | Compositions and methods for treating or preventing diseases or disorders associated with misregulated EIF4E | Oct 21, 2013 | Issued |
Array
(
[id] => 10714106
[patent_doc_number] => 20160060254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'THIAZOLE-BASED INHIBITORS OF SCAVENGER RECEPTOR BI'
[patent_app_type] => utility
[patent_app_number] => 14/436626
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 77
[patent_no_of_words] => 17430
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436626
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436626 | Thiazole-based inhibitors of scavenger receptor BI | Oct 20, 2013 | Issued |
Array
(
[id] => 9518952
[patent_doc_number] => 20140155444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'TETRAHYDRONAPHTHALENE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/059068
[patent_app_country] => US
[patent_app_date] => 2013-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18746
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059068
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059068 | Tetrahydronaphthalene derivatives | Oct 20, 2013 | Issued |